-
Most Recent
Search Results
240 results for dgse
Alphabet Should Be on Every Technology Investor’s Radar Now
Skeptics might claim the Google search engine is “dead,” but a dose of common sense should get investors to lean bullish on GOOG stock.
Revelation Biosciences (REVB) Stock Soars 120%
REVB stock is soaring 120%, but no news explains the rally. The firm recently finished dosing patients for a trial of its hay fever drug.
Meet Your New Robot Overlords – Morning Linkfest (June 6)
InvestorPlace’s daily dose of some of the best reads elsewhere on Wall Street. Today’s top stories: robots, goats and junk bonds.
FDA Approves Ecstasy Trials for PTSD Sufferers
The Food and Drug Administration (FDA) has approved clinical trials for ecstasy to treat PTSD sufferers, including police and firefighters.
Novavax Stock Is Poised to Climb Further
NVAX stock seems positioned for further gains with the firm’s vaccine deliveries set to begin in early 2022.
Novavax: Big Market Potential, Meaningful Stock Upside
Even after a 5,690% gain, NVAX stock looks positioned for further upside with the firm’s focus on bringing vaccines to low-income countries.
Pfizer Looks Like Good Value With Its Vaccine Catalyst and Dividend Yield
Pfizer looks like good value with its vaccine catalyst and dividend yield. PFE stock will be 60% higher within several years after the FDA grants…
Moderna Is a Great Investment Despite Short-Term Headwinds
Following the FDA approval of its vaccine, MRNA stock is set to make some big gains on distribution deals across the globe.
3 Electrical Equipment Stocks to Buy Now
Three electrical equipment stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded…
OCGN Stock Alert: Why Is Ocugen Up 20% Today?
With Ocugen receiving a green light to move ahead with a key retinal therapeutic, OCGN stock jumped on the positive implications.
Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today
Covid-19 pharma stocks like NVAX stock and BNTX stock are making headlines as Joe Biden promises to vaccinate 100 million Americans.
Covid-19 Vaccine Dose Delay Spells Even More Trouble for Novavax Stock
Investors might hope that the spread of the Delta variant will boost NVAX stock, but a recent news release is likely to hinder progress.
5 Stocks With Weak Free Cash Flow — RGSE I CCCL CMLS RLJE
This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Poor Free Cash Flow — I CCCL RGSE CMLS RLJE
This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Ugly Free Cash Flow — GBSN I HTZ RGSE CCCL
This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Poor Free Cash Flow — CETC RGSE I CCCL CMLS
This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.
GW Pharmaceuticals PLC- ADR Is a First-Rate Marijuana Stock (GWPH)
GW Pharmaceuticals (GWPH) brings credibility to a movement that would otherwise have none of its own. GWPH stock belongs on your watch list.
After the Latest Plunge, Catalyst Stock Just Might Be Worth Buying
Disappointing results from one of Catalyst Biosciences’ clinical studies spooked investors. Though the share sell-off in Catalyst stock created paper losses for speculators, the company…
If You’re Placing Bets on Vaccine Winners, Novavax Ought to Be on Your List
Novavax got a manufacturing partner in mid-September to make 2 billion doses. Despite NVAX stock going sideways since then, it remains a buy.
3 Stocks to Watch on Monday: Apple Inc. (AAPL), Microsoft Corporation (MSFT) and Electronic Arts Inc. (EA)
E3 news from Microsoft (MSFT) and Electronic Arts (EA) dominated the weekend, but Apple (AAPL) will kick off Monday with a dose of reality.
5 Exotic ETFs to Buy for a Better Portfolio in 2019
A dose of out of box ETFs could do your portfolio good next year. Here are five great choices to build a better portfolio.
4 – 10 of 240 results
